PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
18457045-1	2007	Oxidatively-modified fibrinogen induces platelet aggregation and potentiates ADP-induced platelet aggregation and production of active oxygen forms in zymosan-stimulated leukocytes.	Zymosan	151-158	fibrinogen beta chain	Homo sapiens	21-31	
12630114-1	2003	The influence of oxidized fibrinogen on the intensity of luminol-dependent chemilumin escence of blood leukocytes, stimulated by opsonized zymosan was studied.	Zymosan	139-146	fibrinogen beta chain	Homo sapiens	26-36	
12420057-1	2002	Fibrinogen intensified luminol-dependent chemiluminescence of blood leukocytes stimulated with opsonized zymosan.	Zymosan	105-112	fibrinogen beta chain	Homo sapiens	0-10	
11693736-4	2001	We performed an in vitro study showing that the chemiluminescence (CL) emission produced by zymosan-activated polymorphonuclear leukocytes (PMNL) was directly related to the concentration of FB, fibrinopeptide A or FB-degradation products (FDP).	Zymosan	92-99	fibrinogen beta chain	Homo sapiens	191-193	
11693736-4	2001	We performed an in vitro study showing that the chemiluminescence (CL) emission produced by zymosan-activated polymorphonuclear leukocytes (PMNL) was directly related to the concentration of FB, fibrinopeptide A or FB-degradation products (FDP).	Zymosan	92-99	fibrinogen beta chain	Homo sapiens	215-217	
7841309-3	1994	Zymosan-treated plasma with 87% complement activation as measured by C3a production using radioimmunoassay was found to induce changes in biophysical characteristics of fibrin network developed in both plasma and purified fibrinogen solution.	Zymosan	0-7	fibrinogen beta chain	Homo sapiens	222-232	
7843797-1	1994	Physiological levels of human fibrinogen markedly inhibited the chemotactic activity of human neutrophils triggered by zymosan-activated serum (ZAS), C5a, or IL-8 in a Boyden chamber assay.	Zymosan	119-126	fibrinogen beta chain	Homo sapiens	30-40	
7843797-9	1994	Fibrinogen also inhibited, in a dose-dependent manner, the oxygen consumption of neutrophils activated by opsonized zymosan.	Zymosan	116-123	fibrinogen beta chain	Homo sapiens	0-10	
627728-1	1978	Analysis of the zymosan (Z)-induced human platelet response with washed platelets, fresh agammaglobulinemic plasma, and purified human IgG has identified a previously unrecognized role of IgG in this reaction, in addition to the previously reported requirements for C and fibrinogen.	Zymosan	16-23	fibrinogen beta chain	Homo sapiens	272-282	
23581432-6	2013	RESULTS: Soluble fibrinogen functioned as a natural antagonist of neutrophil functions that are dependent on MAC-1, such as the respiratory burst induced by unopsonized zymosan and adhesion to ICAM-1 and heparin.	Zymosan	169-176	fibrinogen beta chain	Homo sapiens	17-27	
4610046-0	1974	Requirement for complement components and fibrinogen in the zymosan-induced release reaction of human blood platelets.	Zymosan	60-67	fibrinogen beta chain	Homo sapiens	42-52